Ocular tracking technology
Alcon has announced the acquisition of the ophthalmic division of SensoMotoric Instruments (SMI), a private company based in Berlin, Germany. Alcon said the acquisition provides it with leading ocular surgical guidance technology, such as realtime eye tracking, automatic registration of ocular imaging, and intraocular lens (IOL) positioning and alignment guidance, in order to help improve patient outcomes in cataract surgery. Alcon plans to integrate the newly acquired ocular surgical guidance technology into its existing global cataract portfolio. “This acquisition further strengthens Alcon’s position in the cataract surgery market with an expansion into leading ocular tracking technology,†said Sabri Markabi, senior vice-president, research and development at Alcon. “The state-of-theart guidance technology provides surgeons with customisation options and automated solutions, enabling optimal outcomes for their cataract patients including underlying refractive conditions.â€
• www.alcon.com
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.